Efficacy of azilsartan medoxomil in patients with hypertension and stable coronary artery disease in combination with type 2 diabetes
Aim. To study the effect of azilsartan medoxomil (AZL-M) on the 24-hour blood pressure (BP) profile in patients with hypertension (HTN), type 2 diabetes (T2D) and stable coronary artery disease (CAD).Material and methods. A total of 183 patients with CAD in combination with HTN and T2D took part in...
| Published in: | Рациональная фармакотерапия в кардиологии |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2023-11-01
|
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2948 |